Skip to content

Curasept Gel Afte Rapid DNA 10 Ml

by Curasept S.p.A EUDAMED

Active European Union

Ref CS-04100Model CURASEPT GEL AFTE RAPID DNA 10 ML

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberB-08056746071950 Basic UDI-DIDate26 Aug 2026RegisteredStatusActive
European UnionCE/MDD NumberB-08056746071950 Basic UDI-DIDate26 Aug 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR, CE/MDD Active

Certificates

0 certificates · EUDAMED

No notified-body certificate is listed. Devices of this class are self-declared by the manufacturer.

Specification

EUDAMED

Trade Name
Curasept Gel Afte Rapid DNA 10 Ml
Curasept Gel Afte Rapid DNA
Model / Reference
CURASEPT GEL AFTE RAPID DNA 10 ML, CS-04100
Primary DI / UDI-DI
08056746071950
Basic UDI-DI
B-08056746071950, 805674607AFTEGLP15G3
EMDN Code
Q019007, Q0199
Device Class
Class I
Class IIa
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000009299

Other devices from Curasept S.p.A

See all devices from Curasept S.p.A →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No